Goldman Sachs’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-16,200
| Closed | -$3.33M | – | 6529 |
|
|
2025
Q4 | $3.33M | Hold |
16,200
| – | – | ﹤0.01% | 4128 |
|
|
2025
Q3 | $2.54M | Hold |
16,200
| – | – | ﹤0.01% | 4276 |
|
|
2025
Q2 | $2.72M | Hold |
16,200
| – | – | ﹤0.01% | 3938 |
|
|
2025
Q1 | $2.23M | Buy |
+16,200
| New | +$2.06M | ﹤0.01% | 4068 |
|
|
2024
Q1 | – | Sell |
-32,500
| Closed | -$3.28M | – | 5579 |
|
|
2023
Q4 | $3.28M | Buy |
+32,500
| New | +$3.22M | ﹤0.01% | 3527 |
|
|
2022
Q1 | – | Sell |
-50,000
| Closed | -$2.57M | – | 6588 |
|
|
2021
Q4 | $2.57M | Hold |
50,000
| – | – | ﹤0.01% | 4026 |
|
|
2021
Q3 | $2.47M | Hold |
50,000
| – | – | ﹤0.01% | 3992 |
|
|
2021
Q2 | $2.85M | Buy |
+50,000
| New | +$2.92M | ﹤0.01% | 3872 |
|
|
2020
Q1 | – | Sell |
-50,000
| Closed | -$2.53M | – | 5219 |
|
|
2019
Q4 | $2.53M | Buy |
+50,000
| New | +$2.58M | ﹤0.01% | 3485 |
|
|
2018
Q4 | – | Sell |
-100
| Closed | -$5K | – | 5262 |
|
|
2018
Q3 | $5K | Sell |
100
-132,200
| -100% | -$6.77M | ﹤0.01% | 5504 |
|
|
2018
Q2 | $6.46M | Buy |
132,300
+132,200
| +132,200% | +$7.5M | ﹤0.01% | 2780 |
|
|
2018
Q1 | $6K | Sell |
100
-17,200
| -99% | -$1.18M | ﹤0.01% | 5787 |
|
|
2017
Q4 | $1.06M | Buy |
17,300
+6,800
| +65% | +$420K | ﹤0.01% | 4285 |
|
|
2017
Q3 | $703K | Sell |
10,500
-6,700
| -39% | -$474K | ﹤0.01% | 4855 |
|
|
2017
Q2 | $1.34M | Buy |
17,200
+13,100
| +320% | +$989K | ﹤0.01% | 4184 |
|
|
2017
Q1 | $334K | Sell |
4,100
-2,400
| -37% | -$189K | ﹤0.01% | 5372 |
|
|
2016
Q4 | $468K | Sell |
6,500
-5,000
| -43% | -$361K | ﹤0.01% | 5110 |
|
|
2016
Q3 | $894K | Sell |
11,500
-1,700
| -13% | -$137K | ﹤0.01% | 4513 |
|
|
2016
Q2 | $1.03M | Sell |
13,200
-309,500
| -96% | -$24.7M | ﹤0.01% | 4161 |
|
|
2016
Q1 | $26.4M | Buy |
322,700
+307,500
| +2,023% | +$25M | 0.01% | 1518 |
|
|
2015
Q4 | $1.36M | Sell |
15,200
-257,200
| -94% | -$21.8M | ﹤0.01% | 4006 |
|
|
2015
Q3 | $20.9M | Buy |
272,400
+229,000
| +528% | +$19.1M | 0.01% | 1678 |
|
|
2015
Q2 | $3.63M | Buy |
43,400
+24,200
| +126% | +$2.14M | ﹤0.01% | 3249 |
|
|
2015
Q1 | $1.73M | Sell |
19,200
-21,600
| -53% | -$1.86M | ﹤0.01% | 3933 |
|
|
2014
Q4 | $3.29M | Sell |
40,800
-31,500
| -44% | -$2.49M | ﹤0.01% | 3373 |
|
|
2014
Q3 | $5.42M | Sell |
72,300
-10,600
| -13% | -$771K | ﹤0.01% | 2935 |
|
|
2014
Q2 | $5.68M | Buy |
82,900
+57,000
| +220% | +$3.88M | ﹤0.01% | 2898 |
|
|
2014
Q1 | $1.81M | Sell |
25,900
-300,200
| -92% | -$20.9M | ﹤0.01% | 4071 |
|
|
2013
Q4 | $21.8M | Buy |
326,100
+47,400
| +17% | +$2.9M | 0.01% | 1674 |
|
|
2013
Q3 | $14.5M | Sell |
278,700
-30,500
| -10% | -$1.55M | 0.01% | 1884 |
|
|
2013
Q2 | $14.6M | Buy |
+309,200
| New | +$14.1M | 0.01% | 1768 |
|
Other funds holding CAH
VCM
VPM
Goldman Sachs's CAH Position: Q1 2026 in Review
Goldman Sachs increased its Cardinal Health (CAH) stake by 16% in Q1 2026, buying an estimated $68.9M and bringing the position to 2,371,854 shares worth $501M. The position accounts for 0.06% of the portfolio, ranked #348.
Goldman Sachs first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Goldman Sachs held 2,371,854 shares of Cardinal Health worth $501M as of Q1 2026.
- Goldman Sachs bought 320,121 Cardinal Health shares in Q1 2026, an estimated $68.9M.
- Cardinal Health made up 0.06% of Goldman Sachs's portfolio in Q1 2026, its #348 holding.
- Goldman Sachs first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.